Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
Source abstract
Abstract
Immunosuppressive tumor microenvironments (TMEs) create tremendous obstacles for an effective cancer therapy. Herein, we developed a melittin-RADA32 hybrid peptide hydrogel loaded with doxorubicin (DOX) for a potent chemoimmunotherapy against melanoma through the active regulation of TMEs. The formed melittin-RADA32-DOX (MRD) hydrogel has an interweaving nanofiber structure and exhibits excellent biocompatibility, controlled drug release properties both in vitro and in vivo, and an enhanced killing effect to melanoma cells. A single-dose injection of MRD hydrogel retarded the growth of primary melanoma tumors by more than 95% due to loaded melittin and DOX, with concomitant recruitment of activated natural killer cells in the tumors. Furthermore, MRD hydrogel can activate dendritic cells of draining lymph nodes, specifically deplete M2-like tumor-associated macrophages (TAMs), and produce active, cytotoxic T cells to further defend the cells against remaining tumors, providing potent anticancer efficacy against subcutaneous and metastatic tumors in vivo. Multidose injection of MRD hydrogel eliminated 50% of the primary tumors and provided a strong immunological memory effect against tumor rechallenge after eradication of the initial tumors. Owing to its abilities to perform controlled drug release, regulate innate immune cells, deplete M2-like TAMs, direct anticancer and immune-stimulating capabilities, and reshape immunosuppressive TMEs, MRD hydrogel may serve as a powerful tool for anticancer applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · Immune cells in cancer · Immune Cell Function and Interaction
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, PuAi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430034, China
Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York 14260, United States
Funding
Ministry of Science and Technology of the People's Republic of China · Ministry of Education of the People's Republic of China · Huazhong University of Science and Technology · National Natural Science Foundation of China
References (49)
Show source-provided references
1. 10.1016/j.immuni.2013.07.01210.1016/j.immuni.2013.07.012 ↗
2. 10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
3. 10.1158/1078-0432.CCR-13-327110.1158/1078-0432.CCR-13-3271 ↗
4. 10.1200/JCO.2012.46.365310.1200/JCO.2012.46.3653 ↗
5. 10.1158/0008-5472.CAN-12-012210.1158/0008-5472.CAN-12-0122 ↗
6. 10.1093/jnci/djm13510.1093/jnci/djm135 ↗
7. 10.1021/nn501081510.1021/nn5010815 ↗
8. 10.1021/acsnano.7b0152210.1021/acsnano.7b01522 ↗
9. 10.1158/1078-0432.CCR-05-250310.1158/1078-0432.CCR-05-2503 ↗
10. 10.1172/JCI3153710.1172/JCI31537 ↗
11. 10.2217/imt-2017-002410.2217/imt-2017-0024 ↗
12. 10.1126/science.aaa817210.1126/science.aaa8172 ↗
13. 10.1016/j.biomaterials.2016.05.00810.1016/j.biomaterials.2016.05.008 ↗
14. 10.1016/j.biomaterials.2016.10.04710.1016/j.biomaterials.2016.10.047 ↗
15. 10.1021/acsnano.7b0097810.1021/acsnano.7b00978 ↗
16. 10.1186/1756-8722-6-4710.1186/1756-8722-6-47 ↗
17. 10.7150/thno.1510210.7150/thno.15102 ↗
18. 10.1038/ncomms1319310.1038/ncomms13193 ↗
19. 10.1016/j.ccr.2012.02.02210.1016/j.ccr.2012.02.022 ↗
20. 10.1038/onc.2008.27110.1038/onc.2008.271 ↗
21. 10.4161/cbt.10.11.1343410.4161/cbt.10.11.13434 ↗
22. 10.1038/ni.270310.1038/ni.2703 ↗
23. 10.1038/leu.2017.22610.1038/leu.2017.226 ↗
24. 10.1038/nrc.2015.510.1038/nrc.2015.5 ↗
25. 10.1016/j.jconrel.2017.08.00910.1016/j.jconrel.2017.08.009 ↗
26. 10.1126/scitranslmed.aag294210.1126/scitranslmed.aag2942 ↗
27. 10.1016/j.semcancer.2005.07.00810.1016/j.semcancer.2005.07.008 ↗
28. 10.7150/ijbs.7.65110.7150/ijbs.7.651 ↗
29. 10.1126/science.112913910.1126/science.1129139 ↗
30. 10.1158/0008-5472.CAN-10-290710.1158/0008-5472.CAN-10-2907 ↗
31. 10.1080/2162402X.2015.107437410.1080/2162402X.2015.1074374 ↗
32. 10.1016/j.biomaterials.2010.09.01310.1016/j.biomaterials.2010.09.013 ↗
33. 10.1016/j.jconrel.2017.04.01110.1016/j.jconrel.2017.04.011 ↗
34. 10.1016/j.jconrel.2010.04.02610.1016/j.jconrel.2010.04.026 ↗
35. 10.1039/c2cs15360b10.1039/c2cs15360b ↗
36. 10.1007/s00232990020110.1007/s002329900201 ↗
37. 10.1016/0304-4157(90)90006-X10.1016/0304-4157(90)90006-X ↗
38. 10.1007/s10439-016-1583-910.1007/s10439-016-1583-9 ↗
39. 10.1021/la404363810.1021/la4043638 ↗
40. 10.1021/nn400683s10.1021/nn400683s ↗
41. 10.1021/acsami.7b0643110.1021/acsami.7b06431 ↗
42. 10.1093/jnci/djw18610.1093/jnci/djw186 ↗
43. 10.1021/nl073290r10.1021/nl073290r ↗
44. 10.1016/j.ccr.2013.02.01310.1016/j.ccr.2013.02.013 ↗
45. 10.1016/j.addr.2017.04.01010.1016/j.addr.2017.04.010 ↗
46. 10.1021/acsnano.7b0546510.1021/acsnano.7b05465 ↗
47. 10.2174/156802661566615070111452710.2174/1568026615666150701114527 ↗
48. 10.1039/C6CC01744D10.1039/C6CC01744D ↗
49. 10.1021/jp904251j10.1021/jp904251j ↗